The dried root of Salvia miltiorrhiza (Chinese name: Danshen) listed in the Chinese Pharmacopoeia (CP) is widely used traditional Chinese medicine to treat coronary heart disease, cerebrovascular disease, hepatocirrhosis and against bacteria. The chemical constituents of Salvia miltiorrhiza have been studied extensively and well documented. 1) More than 30 diterpenoid quinone pigments, particularly known as tanshinones have been isolated and identified from Danshen. [2] [3] [4] Tanshinone I, tanshinone IIA, and cryptotanshinone are the main abietane-type diterpense contained in Danshen. The pharmacological tests revealed that tanshinones can dilate coronary arteries, increase coronary flow and protect the myocardium against ischaemia. Some of them have also been used to treat neurasthenic insomnia. In addition, tanshinones have attracted particular attention because they exhibit significant antibacterial, antioxidant, and antitumor activities. 5) And among them, the most abundant and structurally representative bioactive component in the fraction is tanshinone IIA (TS IIA) (Fig. 1) . 6) Then TS IIA is selected as the marker component for the quality control of Danshen and Fufang Danshen tablet in the Chinese Pharmacopoeia (2005). However, TS IIA's bioavailability is very low, which results in difficulties in its gastrointestinal formulation.
Cyclodextrins are cyclic oligosaccharides, containing at least 6 d-(ϩ)-glucopyranose units attached by a-1,4-linkage.
b-Cyclodextrin appears to be the best natural cyclodextrin due to its cavity size, efficient drug complexation, availability in pure form, and relatively low cost. 7) Natural cyclodextrins can be modified to improve the low aqueous solubility. One of the pharmaceutically important cyclodextrin derivatives is 2-hydroxypropyl-b-cyclodextrin (HP-b-CD), which has greater solubilizing capacity and improved safety feature than the parent compound. 8, 9) More and more studies also applied HP-b-CD to improve the solubility, dissolution rate and the oral bioavailability of drugs. [10] [11] [12] [13] The present study is to find the absorptive rate-limiting step of TS IIA via investigating its absorption behavior and to gain a reasonable explanation for the cause leading to low oral bioavailability. Thereafter, we prepared complexation of TS IIA with HP-b-CD by coevaporation and characterized them by differential scanning calorimetry (DSC) and X-ray diffractometry (XRD). The absorption properties of TS IIA from its inclusion complex in rats were investigated. We hope that this research could establish a base for investigating the absorption of the complexation of TS IIA with HP-b-CD in vivo and finding an optimum pharmaceutical carrier for developing the oral preparation of TS IIA. 14, 2007 In this paper, the intestinal permeability of the inclusion complex of tanshinone IIA (TS IIA) ). With the increase of dosage of complex, TS IIA's absorption did not show saturated phenomenon, suggesting its transport mechanism in vivo might primary be passive transport. Besides, the permeability of TS IIA was not apparently influenced by the perfusion section studied, which indicated that there might not exist specific absorption site for TS IIA.
MATERIALS AND METHODS

Materials
moval of organic material using the Elgat Maxima (Bucks, U.K.) water purification system. Animals Male Sprague-Dawley rats weighting 220-250 g were purchased from Laboratory Animal Center of Sichuan University, Sichuan, China. All experiments were approved by the Sichuan University Medical Research Ethical Committee for Animal Experiments. Prior to the experiments, the rats were housed in a temperature and humidity controlled room (23°C, 55% air humidity, 12-h light cycle) with free access to water and standard rat chow. The rats were acclimated for at least 5 d and fasted overnight before the experiments.
HPLC Analysis The HPLC measurements were carried out by using a Shimadzu assembly equipped with a LC-10AT model pump, a SPD-LC10A model UV-VIS detector and CTO-10A model column oven. The mobile phase used was methanol : water (85 : 15); the flow rate was 1.0 ml · min Ϫ1 ; the detection wavelength was 270 nm; the column temperature was 30°C. Mobile phase was filtered through a type HA, 0.45 mm membrane filter (Millipore Corporation) and deaerated under reduced pressure.
Preparation of Solid Complexes
All the complexes as well as physical mixture were prepared with 1 : 1 molar ratios. The weights taken for 1 : 1 ratio were 1.06 g of the TS IIA and 5.37 g of HP-b-CD.
The inclusion complex (IC) between the TS IIA and HPb-CD was prepared by freeze-drying method. The required stoichiometric amount of the TS IIA was added, under magnetic stirring, to an aqueous solution of HP-b-CD. After 1 h at 30°C of agitation, the resulting solution was subjected to a process of lyophilization in a freeze-dryer (Lyph-lock 6 apparatus, Labconco) for 3 d.
The physical mixture (PM) of the TS IIA and HP-b-CD was in the same weight ratio of the inclusion complex and prepared by simple mechanical mixing.
Differential Scanning Calorimetry (DSC) Approximately 5 mg of the TS IIA, HP-b-CD and inclusion complexes were subjected to DSC analysis, using a SEIKO EXS-TAR6000 TGIDTA6300. Alumina was used as a reference material and the scanning rate was 10.00°C · min
Ϫ1
, with the scanning temperature range of 50 and 400°C.
X-Ray Diffractometry (XRD) Powder X-ray diffraction patterns were obtained from a Philips MRD diffractometer. Samples were irradiated with monochromatized Cu/C radiation and analyzed between 2q angles of 5 and 75°at a scan rate of 1 min
. Duplicate determinations were made for each of the samples.
In Situ Rat Intestinal Perfusion Experiment. Composition of Perfusion Solutions Freshly prepared Krebs bicarbonate Ringer (KR) buffer was prepared with 114.3 mM NaCl, 4.2 mM KCl, 24.9 mM NaHCO 3 , 12.2 mM glucose, 1.2 mM MgCl 2 , 1.25 mM CaCl 2 , 1.65 mM Na 2 HPO 4 and 0.3 mM NaH 2 PO 4 , and adjusted to pH 7.4 with carbogen (95% O 2 ϩ5% CO 2 ) bubbling. 14) In addition, in this experiment, the phenolsulfonphthalein (psp) was added into the blank KR buffer to act as a nonabsorbable marker to help identify any transfer of water into or out of the intestine and to monitor the structural integrity of the intestinal segment. 15) Recirculating Intestinal Perfusion of Rats: Experimental Setup The rats were anaesthetized by intraperitoneal administration of sodium pentobarbital solution (40 mg · kg Ϫ1 ). To maintain normal body temperature, the rats were placed under a surgical lamp. The temperature was measured in the segment and was found to be between 36 and 37°C. The abdominal cavity was cut opened with a midline incision and upper small intestine was isolated. Intestinal (10 cm) segments were inserted by an inlet cannula and tiedoff at the duodenum (2 cm from the pyloric sphincter), the jejunum (just distal to the ligament of Treitz) or the ileum (immediately proximal to the cecum). 16) Initially, the intestinal segment was rinsed with isotonic saline (37°C) until the outlet solution was clear. The preparation time took approximately 15 min. The cannula was then connected to two plastic tubes that were connected to a constant-flow pump (HL-2, XiangShan Lid., China). [17] [18] [19] As soon as the experiment began, the perfused intestinal segment was repositioned in the abdominal cavity, unimpeded axial flow was maintained, and the abdominal incision closed with wound clips. The recirculation fluid flowed into the segment at a rate of 1.0 ml · min
. Each perfusion experiment lasted for 120 min, and 0.5 ml perfusion was quantitatively taken at 15 min intervals. Then the equal volume of fresh blank psp KR buffer was added into the recirculation fluid. The samples were filtered through 0.45 mm membrane filters. The first 20% of the filtrate was discarded, and then the total concentration of the TS IIA in the subsequent filtrate was analyzed by HPLC. Each experiment was replicated on 6 rats.
Intestinal Absorption Study Protocol. Comparison of the Absorption Behavior of Free and Complexed TS IIA Uncomplexed and complexed TS IIA dispersed in KR buffer, equivalent to 5 mg · ml Ϫ1 of TS IIA, were used as perfusate I and perfusate II. The intestinal behavior of free and complexed TS IIA was comparatively studied at the whole small intestine. The results were calculated and fitted via the following both mathematical models.
The Intestinal Absorption of Complexed TS IIA Complexed TS IIA of three different concentrations from low to high (50, 100, 150 mg · ml Ϫ1 ) were prepared. The absorption parameters of TS IIA at each concentration in the three intestinal segments (duodenum, jejunum, ileum) were tested by the in situ method. Information on the absorption of TS IIA in rat intestinal could be obtained from the absorptive rate constant (K a ), apparent permeability coefficient (P app ) and absorptive fraction in unit time (P%).
Data Analysis The absorption rate of oral administration depended on the rate-limiting step in the drug dissolution and in the drug mucosal permeability.
When the rate-limiting step is drug dissolution, the drug absorption follows a nonlinear kinetics. The time course for the concentration of drug in the intestinal absorption can be estimated from the Michaelis-Menten expression 20) : (1) Where V max is the maximum rate of absorption and K m is the Michaelis constant. ϪdC/dt is the rate of absorption.
The rate of change in perfusate solution concentration, together with the drug concentration at the midpoint of each sampling period, C m , can be incorporated into a number of expressions to solve for V max and K m . From the Eq. 1 the following typical expression can be derived:
When the rate-limiting step is drug mucosal permeability, the time course for the concentration of drug in the intestinal absorption can be estimated from the Fick's equation 21) : (3) where, ϪdC/dt is absorptive rate, D is the permeability coefficient in membrane, k is the distribution coefficient, A is the surface area of the absorbing membrane, h is the thickness of the absorbing membrane, (CϪC b ) represents the concentration difference of the drug diffusion direction, i.e., concentration difference between absorbing membrane thickness (between inside and outside of membrane).
When C is much greater than C b and K a is equal to DkA/h, from the Eq. 3 the following equation can be derived: (4) Where, K a is the absorptive rate constant, Eq. 4 can be integrated, then be written in a form which includes concentration at time 0 and concentration at any given time t. At time 0, concentration is the initial concentration. Thus, Eq. 4 becomes
There are two kinds of methods to assess the absorptive rate-limiting step. 22) One of which is to choose the model with the larger correlation coefficient, another assessment is to utilize the maximum R 2 method. The equation expression is: (6) Where, y i is the actuality value,ŷ i is the computed value obtained by the two Eqs. 2 and 5. The model with the larger R 2 value indicates to accord with the actual state. ϭ0.9998). From the obtained analytical parameters it can be concluded that the method fulfils analytical requirements with an adequate repeatability (Ͻ2%). The mean recovery was 100.87Ϯ5.45% (nϭ3). Figure 2 showed the DSC thermograms of TS IIA and HP-b-CD corresponding binary systems. The thermogram of the TS IIA revealed an endothermic peak at 219.0°C, corresponding to its melting point. The thermogram of HP-b-CD showed a very broad endothermic effect, which attained a maximum around 100°C and 50°C, due to the dehydration effect. The thermogram of PM still demonstrated the melting point of the TS IIA at 218.6°C, indicating that an inclusion complex could not be obtained by simply blending the drug and HP-b-CD. The complete disappearance of the TS IIA endothermic peak was observed for the complex, indicating that the TS IIA was incorporated in the HP-b-CD cavity. Further evidence of inclusion complex formation was observed from X-ray powder diffractograms. Figure 3 showed the X-ray diffractograms of the TS IIA, HP-b-CD and corresponding complexes. The diffraction pattern of the TS IIA displayed crystallinity, which was shown by the sharp peaks, whereas HP-b-CD was amorphous in the solid state. The diffraction pattern of PM system was found to be the simple sum of the TS IIA and HP-b-CD. The diffractogram of IC did not exhibit peaks corresponding to the TS IIA and was practically identical to those of the amorphous HP-b-CD. Thus, the X-ray diffraction analysis confirmed the DSC results: the diffraction peaks relevant to crystalline TS IIA were no longer detectable in the inclusion complex, and the reduction of the degree of crystallinity of the drug could be taken as an indication of complexation. The complex system displayed diffuse diffraction pattern (identical to that of HP-b-CD without drug peaks), indicating the entirely amorphous nature of TS IIA in the complex. Comparison of the Absorption Behavior of Free and Complexed TS IIA The upper boundary of the concentration range (5 mg · ml
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) was limited because of the low aqueous solubility of free TS IIA. In 2 h in situ rat intestinal perfusion experiments, the average remaining concentration values of TS IIA in the perfusate I, II were showed in Table 1 . Fitting the data in the table by the above two models, the correlation coefficients and the R 2 of the regression equations were showed in Table 2 . The results indicated the absorption process of the uncomplexed TS IIA was consistent with the first model and dissolution was the absorptive rate-limiting step, however, the absorption process of the inclusion complex was more suitable to the second model and the absorptive rate-limiting step was the intestine membrane permeation process. In fact, some reports indicated that CDs had been investigated the interaction between CDs with intestinal membrane and demonstrated the mechanism of the enhancement of intestinal absorption of drugs. 25, 26) Sharma et al. came to the conclusion that perturbation of intestinal membrane by b-CD as well as HP-b-CD would result into release of proteins from enterocytes into the lumen. This was due to extraction of lipoidal constituents by phenomenon of inclusion complex formation leading to disorder in membrane lipid and/or interacting with hydrophilic domains of membrane. This maybe resulted in increased permeability across intestinal membrane and showed the potential to improve oral delivery.
The Absorption Parameters of the Complexed TS IIA According to the absorption process, which fits the Fick's formula, the absorption parameter K a was calculated by Eq. 5. In the usual way, the calculating method of the absorptive fraction in unit time (P%) was quantified using Eq. 7. (7) Where C 0 is the initial TS IIA concentration in perfusate, V 0 is the initial volume of perfusate. C t is the final TS IIA concentration in perfusate; V t is the final volume of perfusate. t is the time of circulation of perfusate.
Intestinal permeability, directly reflecting the interactions of the molecule with the tissue was affected by the physiological properties of the tissue as well as the physicochemical properties of the transported compound. Thus, permeability measurement is important to predict absorption of a compound. Apparent permeability coefficient (P app ) was calculated according to the Eq. 8 (8) Where K a is the absorption rate constant according to the second model, A is the area of exposed tissue and 3600 represents 3600 seconds per hour.
In 2 h in situ intestinal perfusion experiments, after the administrations of three concentrations of complexed TS IIA in each small intestinal tissue, including duodenum, jejunum and ileum, the average parameters were listed in Table 3 . Complexed TS IIA exhibited an intestinal permeability ranging from 3.16ϫ10 Ϫ5 cm · s Ϫ1 in the duodenum (50 mg · ml Ϫ1 ) to 4.11ϫ10 Ϫ5 cm · s Ϫ1 in the jejunum (100 mg · ml
). A oneway ANOVA test was used to assess significant difference between P app values for TS IIA in different concentrations at each segment. Statistical analysis results showed the TS IIA permeability had no significant difference regardless of in the proximal, mean and distal segments when the initial perfusion solution concentration increased from 50 to 150 mg · ml Ϫ1 (pϾ0.05). The data suggested that the absorption process of TS IIA from the inclusion complex was linear for the range of perfused concentration. The ways of drug absorbed from gastrointestinal tract into system circulation usually can be divided as passive transport, facilitated diffusion and active transport. 27) Unlike the active process, the passive diffusion of a compound through the intestinal cell membrane was driven by the concentration gradient from the intestinal lumen to the blood supply with a constant permeability coefficient. In this study, varying the donor concentration of TS IIA did not lead to a significant statistical deviation in the permeability coefficient at various intestinal segments, which indicated the absorption processes of TS IIA had no saturation phenomenon. This suggested that a passive diffusion process might not be excluded for transport of TS IIA from the complex through the intestinal membrane. The statistical test of P app at the same concentration in different segments was performed the same as above. Comparisons across the different segments showed that the permeability at 100 mg · ml Ϫ1 was higher in the jejunum compared with the other segments, but did not reach statistical significance (pϾ0.05). In the other concentration, the permeability of TS IIA was not apparently influenced by the perfusion section studied. The results indicated that the absorption of TS IIA had not the specific site in the small intestine.
Intestinal absorption is a complex process where not all underlying mechanisms are fully understood, though the in situ technique provides the advantages of experimental control (e.g. compound concentration, pH, osmolality), ability to study regional differences, and an intact intestinal blood supply and innervations of the animal. 28) Several factors, such as, intestinal disease, surgery and the choice of anaesthetic might influence the absorption parameters. For instance, it was recently reported that surgery and anaesthetics might cause anoxia and decease in intestinal blood flow, motility and energy supply, which consequent decreases of both passive and active transport. 17) Therefore, it is likely that no single experimental method will be ideal to study absorption process and that maximum information will often require corroborative evidence from more than one method. 29) Further studies on the human Caco-2 cells (the human colon carcinoma cells) and in vivo animal experiments are in progress to verify the present results. 30) The correlations are being established with data generated from the in situ rat perfusion and the Caco-2 culture model. 
